Eli Lilly said it is investing another $5.3 billion in a manufacturing plant in Lebanon, Indiana, to expand the supply of its highly popular weight loss drug Zepbound, diabetes treatment Mounjaro ...

LOUISVILLE, Ky. (WAVE) - Eli Lilly and Company, a pharmaceutical company headquartered in Indianapolis, plans to investment more at the LEAP Research and Innovation District in Lebanon. That’s ...

On an investment spree with billions of dollars’ worth of projects ongoing globally, Indianapolis-based Eli Lilly and Company ...

Analysts expect the Indianapolis, Indiana-based company to report quarterly earnings at $5.08 per share, up from $2.49 per ...

Eli Lilly has followed Novo Nordisk ... in the products before the end of the year, with investment projects ongoing in North Carolina and Indiana in the US. The new facility in Germany is ...

Eli Lilly (LLY) stock rises as company posts Q4 2024 results, beating expectations with a twofold rise in revenue from weight ...

Eli Lilly, based in Indiana, employed more than 41,000 people ... Iowa manufacturing plant and closing research and development offices in New Jersey and Shanghai, China. The moves will result ...